Duration of Androgen Suppression in the Treatment of Prostate Cancer-Reference-Cited by-同舟云学术

Duration of Androgen Suppression in the Treatment of Prostate Cancer

Published:2009-06-11 Issue:24 Volume:360 Page:2516-2527
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Bolla Michel,de Reijke Theodorus M.,Van Tienhoven Geertjan,Van den Bergh Alphonsus C.M.,Oddens Jorg,Poortmans Philip M.P.,Gez Eliahu,Kil Paul,Akdas Atif,Soete Guy,Kariakine Oleg,van der Steen-Banasik Elsbietha M.,Musat Elena,Piérart Marianne,Mauer Murielle E.,Collette Laurence

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa0810095

Cited by 842 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Effects of Prostate Radiotherapy Intensified with Pelvic Nodal Radiotherapy and Androgen Deprivation Therapy on Myelosuppression: Single-Institution Experience;Current Oncology;2024-09-13

2. Comparative Analysis of PSA Nadir and Time to PSA Nadir on Clinical Outcomes in Patients with De Novo Spine Metastasis of Prostate Cancer Undergoing Androgen Deprivation Treatment (ADT) Only vs. ADT Intensification;annals of urologic oncology;2024-08-09

3. Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer;Nature Reviews Urology;2024-08-07

4. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent;European Urology;2024-08

5. Elective Pelvic Lymph Node Radiation Therapy and the Risk of Death in Patients With Unfavorable-Risk Prostate Cancer: A Postrandomization Analysis;Journal of Clinical Oncology;2024-07-20